Navigation Links
Hope for Inherited, Dangerously High Cholesterol
Date:3/14/2010

New drug reduces LDL in people with rare genetic condition, researchers say

SUNDAY, March 14 (HealthDay News) -- A new drug called mipomersen reduced low-density lipoprotein (LDL) "bad" cholesterol by nearly 25 percent when added to current therapy in people with a rare genetic condition that causes extremely high cholesterol, a new study finds.

Mipomersen is designed to decrease the formation of apolipoprotein B (the main structural protein in LDL cholesterol) and its release from the liver or intestine. This reduces circulating LDL cholesterol concentrations.

Inherited high cholesterol (homozygous familial hypercholesterolemia) affects one in every one million people. Patients with the disorder have severely elevated LDL cholesterol and a high risk of early cardiovascular disease. If untreated, these patients rarely live past the age of 30.

This phase 3 clinical trial included 51 patients with homozygous FH who were already taking lipid-lowering drugs, including high-dose statins. The patients were randomly selected to receive either 200 milligrams of mipomersen or placebo per week for 26 weeks.

At the end of the treatment period, LDL cholesterol levels had decreased 24.7 percent in the mipomersen group, compared with 3.3 percent in the placebo group.

"Mipomersen could be a valuable addition to the drugs used in the management of homozygous FH and should prove useful in the management of other forms of severe refractory hypercholesterolemia," wrote an international team of researchers led by Frederick Raal of the University of Witwatersrand, Johannesburg, South Africa.

The study was published online March 13 in advance of print publication this week in The Lancet, and was slated to be presented Saturday at the annual meeting of the American College of Cardiology in Atlanta.

More information

The U.S. National Library of Medicine has more about homozygous familial hypercholesterolemia.



-- Robert Preidt



SOURCE: The Lancet, news release, March 13, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Arab-American women need supplement to boost dangerously low vitamin D levels
2. Department of Health Urges Pennsylvanians to Prepare For Dangerously Cold Weather
3. OIG Report Confirms Dangerously Thin Margins for Community Pharmacy
4. Intense Cholesterol, Blood Pressure Therapies Dont Help Type 2 Diabetics
5. Thyroid hormone analogue for treating high cholesterol
6. Thyroid Hormone Analogue for Treating High Cholesterol
7. New Study Finds Cholesterol-Related Gene Associated with Mild Cognitive Impairment, a Precursor of Alzheimer's Disease
8. Teamwork Unlikely to Improve Cholesterol Levels
9. A common cholesterol drug fights cataracts, too
10. QuickMedial Praises New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer's Disease or Vascular Dementia
11. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... , ... The iaedp Foundation, the premier provider of educational programs and training ... the full spectrum of disordered eating, announced today that the 2017 Symposium set a ... states and several countries converged on the Green Valley Resort in Las Vegas. ...
(Date:3/24/2017)... Arizona (PRWEB) , ... March 24, 2017 , ... ... Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during the ...
(Date:3/24/2017)... PA (PRWEB) , ... March 24, 2017 , ... ... Oncology Nursing Society (ONS) wanted to create a communications platform that positions them ... this goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy gaining ... issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... causes around the world. , Running for charity has become a multi-million ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Invivotek, LLC, a Genesis Biotechnology ... vivo pharmacology contract research organization (CRO), announced the ... newly expanded preclinical research facility in Hamilton, ... cleaner, renewable energy source to reduce costs and lessen ... the Genesis Solar Farm follows Invivotek,s recent expansion from ...
(Date:3/24/2017)... and PUNE, India , March 24, 2017 ... "Spine Bone Stimulators Market: Global Opportunity Analysis and Industry Forecast, 2014-2022," the spine ... to reach $724 million by 2022, growing at a CAGR of 3.6% during ... ... Allied Market Research Logo ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Share, Development, Growth and Demand Forecast to 2022" report to their ... The global wound ... to grow at a CAGR of 6.7% during 2016-2022 Among ... held the largest share in the global market in 2015. Among the ...
Breaking Medicine Technology: